Release Date: August 08, 2024
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you provide an update on the progress of fixing underperforming plants? A: Tim French, Chief Operating Officer, stated that they are on track to have the group of underperforming plants at break-even or better. As of Q2, nine out of the seven plants are profitable, and all are performing better than the previous year.
Q: How is the Chinese joint venture performing, and do you expect this trend to continue? A: Harold Bevis, CEO, explained that the JV is performing well, driven by a strong hybrid vehicle market in China. The business has benefited from cost reduction programs and is expected to continue performing better year-over-year, although the second half may not be as strong as the first.
Q: What are the expectations for the strategic refinancing, and how will it impact the company? A: Christopher Bohnert, CFO, mentioned that they are in the middle of the refinancing process, expecting to secure lower rates than the current 14% range. The refinance aims to reduce overall cost of capital and potentially pay down some preferred debt, aiding the company's transformation and growth.
Q: How is NN Inc managing pricing actions, and what impact did they have in the quarter? A: Harold Bevis, CEO, noted that pricing impact was minimal, with some contractual price reductions in mobile solutions. The power and medical businesses are largely PO-based, with inflation pricing and precious metals passthroughs contributing to the pricing dynamics.
Q: Can you elaborate on the new $100 million target for the medical business and the timeline to achieve it? A: Harold Bevis, CEO, explained that they are expanding capacity with new machines to support growth in the medical segment. The goal is to reach $100 million in revenue over three years, supported by both organic growth and potential acquisitions.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.